PubMed=1389533; DOI=10.1016/0959-8049(92)90031-V
Lahm H., Petral-Malec D., Yilmaz-Ceyhan A., Fischer J.R., Lorenzoni M., Givel J.-C., Odartchenko N.
Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1.
Eur. J. Cancer 28:1894-1899(1992)

PubMed=7790122; DOI=10.1002/ijc.2910610618
Prado I.B., Laudanna A.A., Carneiro C.R.W.
Susceptibility of colorectal-carcinoma cells to natural-killer-mediated lysis: relationship to CEA expression and degree of differentiation.
Int. J. Cancer 61:854-860(1995)

PubMed=11323753; DOI=10.1590/S0100-879X2001000500014
Solimene A.C.E.C., Carneiro C.R.W., Melati I., Lopes J.D.
Functional differences between two morphologically distinct cell subpopulations within a human colorectal carcinoma cell line.
Braz. J. Med. Biol. Res. 34:653-661(2001)

PubMed=11414198; DOI=10.1007/s004320000207
Lahm H., Andre S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H., Wolf E., Gabius H.-J.
Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
J. Cancer Res. Clin. Oncol. 127:375-386(2001)

PubMed=12886464; DOI=10.1590/S0100-879X2003000800016
Roela R.A., Brentani M.M., Katayama M.L.H., Reis M., Federico M.H.H.
Simultaneous changes in the function and expression of beta 1 integrins during the growth arrest of poorly differentiated colorectal cells (LISP-1).
Braz. J. Med. Biol. Res. 36:1091-1099(2003)